These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 18471148)

  • 1. Pharmacokinetics of zonisamide and drug interaction with phenobarbital in dogs.
    Orito K; Saito M; Fukunaga K; Matsuo E; Takikawa S; Muto M; Mishima K; Egashira N; Fujiwara M
    J Vet Pharmacol Ther; 2008 Jun; 31(3):259-64. PubMed ID: 18471148
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disposition and safety of zonisamide after intravenous and oral single dose and oral multiple dosing in normal hound dogs.
    Boothe DM; Perkins J
    J Vet Pharmacol Ther; 2008 Dec; 31(6):544-53. PubMed ID: 19000278
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-lasting enhancement of CYP activity after discontinuation of repeated administration of phenobarbital in dogs.
    Fukunaga K; Saito M; Matsuo E; Muto M; Mishima K; Fujiwara M; Orito K
    Res Vet Sci; 2009 Dec; 87(3):455-7. PubMed ID: 19406444
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of urine pH modification on pharmacokinetics of phenobarbital in healthy dogs.
    Fukunaga K; Saito M; Muto M; Mishima K; Fujiwara M; Orito K
    J Vet Pharmacol Ther; 2008 Oct; 31(5):431-6. PubMed ID: 19000262
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rufinamide: clinical pharmacokinetics and concentration-response relationships in patients with epilepsy.
    Perucca E; Cloyd J; Critchley D; Fuseau E
    Epilepsia; 2008 Jul; 49(7):1123-41. PubMed ID: 18503564
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lack of a clinically significant effect of zonisamide on phenytoin steady-state pharmacokinetics in patients with epilepsy.
    Levy RH; Ragueneau-Majlessi I; Garnett WR; Schmerler M; Rosenfeld W; Shah J; Pan WJ
    J Clin Pharmacol; 2004 Nov; 44(11):1230-4. PubMed ID: 15496640
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of single-dose rectal zonisamide administration in normal dogs.
    Brewer DM; Cerda-Gonzalez S; Dewey CW; Boothe D; Van Horne K
    J Vet Intern Med; 2015; 29(2):603-6. PubMed ID: 25818215
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics and interactions of digoxin with phenobarbital in dogs.
    Ravis WR; Pedersoli WM; Turco JD
    Am J Vet Res; 1987 Aug; 48(8):1244-9. PubMed ID: 3631715
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of zonisamide following rectal administration to healthy dogs.
    Michaels JR; Hodshon AJ; Thomas WB; Boothe DM; Williams L
    Am J Vet Res; 2016 Dec; 77(12):1374-1380. PubMed ID: 27901384
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Carbamazepine pharmacokinetics are not affected by zonisamide: in vitro mechanistic study and in vivo clinical study in epileptic patients.
    Ragueneau-Majlessi I; Levy RH; Bergen D; Garnett W; Rosenfeld W; Mather G; Shah J; Grundy JS
    Epilepsy Res; 2004 Nov; 62(1):1-11. PubMed ID: 15519127
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of phenobarbital in horses after single and repeated oral administration of the drug.
    Knox DA; Ravis WR; Pedersoli WM; Spano JS; Nostrandt AC; Krista LM; Schumacher J
    Am J Vet Res; 1992 May; 53(5):706-10. PubMed ID: 1524295
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics of florfenicol and its metabolite, florfenicol amine, in dogs.
    Park BK; Lim JH; Kim MS; Hwang YH; Yun HI
    Res Vet Sci; 2008 Feb; 84(1):85-9. PubMed ID: 17570454
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interactions of phenobarbital with propranolol in the dog. 2. Bioavailability, metabolism and pharmacokinetics.
    Vu VT; Bai SA; Abramson FP
    J Pharmacol Exp Ther; 1983 Jan; 224(1):55-61. PubMed ID: 6848749
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Zonisamide: pharmacokinetics, efficacy, and adverse events in children with epilepsy.
    Wallander KM; Ohman I; Dahlin M
    Neuropediatrics; 2014 Dec; 45(6):362-70. PubMed ID: 25133701
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Steady-state pharmacokinetics of zonisamide, an antiepileptic agent for treatment of refractory complex partial seizures.
    Kochak GM; Page JG; Buchanan RA; Peters R; Padgett CS
    J Clin Pharmacol; 1998 Feb; 38(2):166-71. PubMed ID: 9549648
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Imipramine-cimetidine interaction: impairment of clearance and enhanced absolute bioavailability.
    Abernethy DR; Greenblatt DJ; Shader RI
    J Pharmacol Exp Ther; 1984 Jun; 229(3):702-5. PubMed ID: 6726654
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analytical determination and pharmacokinetics of robenacoxib in the dog.
    Jung M; Lees P; Seewald W; King JN
    J Vet Pharmacol Ther; 2009 Feb; 32(1):41-8. PubMed ID: 19161454
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Zonisamide concentrations during pregnancy.
    Oles KS; Bell WL
    Ann Pharmacother; 2008 Jul; 42(7):1139-41. PubMed ID: 18577760
    [TBL] [Abstract][Full Text] [Related]  

  • 19. General pharmacology of the novel antiepileptic compound zonisamide. 2nd communication: effects on cardiovascular, visceral, renal and blood functions.
    Nakatsuji K; Matsuno Y; Nakamura N; Fujitani B; Ito T; Kadokawa T
    Arzneimittelforschung; 1987 Oct; 37(10):1131-6. PubMed ID: 3435584
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetic interaction of zonisamide in rats. Effect of other antiepileptics on zonisamide.
    Kimura M; Tanaka N; Kimura Y; Miyake K; Kitaura T; Fukuchi H
    J Pharmacobiodyn; 1992 Nov; 15(11):631-9. PubMed ID: 1289498
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.